Form D · Other Health Care

Axiomed, LLC

Malden, MA · CIK 0001696013

Offering snapshot reported Mar 16, 2023 · SEC filing

Reported sold
$320K
Offering amount: $30M
Investors reported
6
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Nov 19, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$160K$320KJul 20, 2022: $70,000.00Jul 20, 2022Mar 16, 2023: $320,000.00Mar 16, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$70,000 → $320,000
  • Reported investors1 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 16, 2023Amendment$320,000$250,000vs Jul 20, 20226SEC filing
Jul 20, 2022Initial$70,000No comparison1SEC filing
Nov 21, 2017Initial$100,000No comparison1SEC filing
Jan 26, 2017Initial$1,025,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-453133
we modified the total offering amount from 12Million to 30Million

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NANone

Source: Form D, filed Mar 16, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aditya Humad Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
350 Main Street
Malden, MA, 02148